Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Solano Pharmaceuticals

Solano Pharmaceuticals
2013 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$226K LATEST DEAL AMOUNT
1 INVESTORS
Description

Owner and operator of a biopharmaceutical company. The company develops a class of mitochondrial-targeted antioxidants for the treatment of neurodegenerative diseases.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 820 Heinz Avenue
  • Berkeley, CA 94710
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Solano Pharmaceuticals’s full profile, request a free trial.

Solano Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 15-Jun-2014 $226K Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Solano Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0

Solano Pharmaceuticals Executive Team (3)

Name Title Board
Seat
Contact
Info
Janet Leeds Chief Executive Officer
Cynthia McMurray Co-Founder
Peter Wipf Co-Founder